货号:A380132
同义名:
Cuc B; NSC 144154
Cucurbitacin B是一种高度氧化的四环三萜,具有抗癌、抗炎和抗氧化活性,通过抑制癌细胞增殖、迁移及诱导细胞凋亡,用于肿瘤与慢性炎症研究。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Microtubule, a component of the cytoskeleton, plays crucial roles in various fundamental cell functions, including mitotic regulation, maintenance of cell morphology, intracellular motility and macromolecules and organelles trafficking. Cucurbitacin B, an oxygenated tetracyclic triterpenoid compound extracted from the Thai medicinal plant Trichosanthes cucumerina L., has several biological activities including anti-inflammatory, antimicrobial and anticancer through disruption of the microtubule network. It exhibited a dose-dependent inhibitory effect with the IC50 of 4.12 μM and 3.68 μM for MCF-7 and MDA-MB-231 cells, respectively. In the same cell lines treated with 2.5 μM and 5 μM cucurbitacin B for 24 hr, blockage at G2/M and apoptotic induction were observed in cucurbitacin B-treated cells. Further, cucurbitacin B treatment for 24 hr significantly induced apoptosis approximately 30% to 40% of breast cancer cells population. Compared with the control cells, cucurbitacin B treated cells exhibited obvious aggregation of α-tubulin. The changes were observed within 15 min during incubation with cucurbitacin B[3]. In the nude mice bearing human MDA-MB-231 breast cancer cells, tumor volume was reduced by 55% in the group that received Cucurbitacin B (1.0 mg/kg) for 6 weeks compared with vehicle controls[4]. |
| Concentration | Treated Time | Description | References | |
| CRMM2 | 0.15 μM | 72 h | Inhibited cell proliferation | Acta Pharm Sin B. 2022 Oct;12(10):3861-3876 |
| A549-GR cells | 15 nM | 48 h | Inhibited EMT, decreased EGFR expression and ROS production | Chin Med. 2022 Feb 19;17(1):24 |
| A549 cells | 5, 10, 15 nM | 48 h | Inhibited TGF-β1-induced EMT, reversed cell morphology changes, increased E-cadherin expression, decreased N-cadherin and Vimentin expression | Chin Med. 2022 Feb 19;17(1):24 |
| CRMM1 | 0.24 μM | 72 h | Inhibited cell proliferation | Acta Pharm Sin B. 2022 Oct;12(10):3861-3876 |
| CM-AS16 | 0.08 μM | 72 h | Inhibited cell proliferation | Acta Pharm Sin B. 2022 Oct;12(10):3861-3876 |
| CM2005.1 | 0.38 μM | 72 h | Inhibited cell proliferation | Acta Pharm Sin B. 2022 Oct;12(10):3861-3876 |
| Huh7 cells | 4.1 μM | 24 h | To evaluate the inhibitory effect of CuB on Huh7 cell proliferation, results showed CuB significantly inhibited cell proliferation | ACS Cent Sci. 2022 Aug 24;8(8):1102-1115 |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c nude mice | Human lung cancer (A549) xenograft model | Intravenous injection | 472 nM CuB | Every other day for 14 days | Evaluate the anticancer effects of CDNVs in vivo, results showed CDNVs significantly inhibited tumor growth without obvious toxicity. | Int J Nanomedicine. 2022 Aug 10;17:3583-3599 |
| C57BL/6J mice | B16-F10 lung cancer metastasis model | Intratracheal administration | 0.25 mg/kg, 0.5 mg/kg | Once daily for 14 days | Inhibited lung cancer metastasis | Chin Med. 2022 Feb 19;17(1):24 |
| BALB/c mice | H22 xenograft model | Intraperitoneal injection | 1 or 5 mg/kg | Once daily for 14 days | To evaluate the anti-HCC effect of CuB in vivo, results showed CuB significantly inhibited tumor growth and promoted immune cell infiltration | ACS Cent Sci. 2022 Aug 24;8(8):1102-1115 |
| NCG mice | CRMM2 xenograft model | Intragastric | 1 mg/kg | Five times per week for five weeks | Significantly inhibited tumor progression without obvious side effects | Acta Pharm Sin B. 2022 Oct;12(10):3861-3876 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02858388 | Otitis Media With Effusion | Phase 3 | Completed | - | Italy ... 展开 >> San Gennaro Hospital Naples, Italy, 80136 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.79mL 0.36mL 0.18mL |
8.95mL 1.79mL 0.89mL |
17.90mL 3.58mL 1.79mL |
|
| CAS号 | 6199-67-3 |
| 分子式 | C32H46O8 |
| 分子量 | 558.7 |
| SMILES Code | O[C@H](C1)[C@@]([C@@](C)(O)C(/C=C/C(OC(C)=O)(C)C)=O)([H])[C@](C2)(C)[C@]1(C)[C@]3([H])CC=C4C(C)(C)C([C@@H](O)C[C@@]4([H])[C@]3(C)C2=O)=O |
| MDL No. | MFCD07778083 |
| 别名 | Cuc B; NSC 144154; NSC 49451 |
| 运输 | 蓝冰 |
| InChI Key | IXQKXEUSCPEQRD-DKRGWESNSA-N |
| Pubchem ID | 5281316 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(187.94 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1